Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability of VOWST™, the First and Only FDA-Approved Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection
Monday, June 05, 2023Seres Therapeutics Inc Nasdaq MCRB and Nestl Health Science today announced that VOWST fecal microbiota spores livebrpk is now commercially available for patients VOWST formerly called SER is the first and only US Food and Drug Administration FDAappr...
ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities
Monday, June 05, 2023ITM Isotope Technologies Munich SE ITM a leading radiopharmaceutical biotech company today announced an equity investment round of million led by Temasek with participation from BlackRock Alternatives Qatar Investment Authority QIA Nextech ATHOS and...
Evaxion AI Technology Identifies Cancer Vaccine Targets Associated with Increased Progression-Free Survival in Melanoma Patients in Phase I Clinical Trial of EVX-01
Monday, June 05, 2023Evaxion Biotech AS NASDAQ EVAX Evaxion or the Company a clinicalstage biotechnology company focused on the development of AIenabled Immunotherapies today presented encouraging clinical data from its Phase I doseescalation study of EVX in metastatic m...
Janssen is applying to the European Commission for approval of a new indication for CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) for the earlier treatment of patients with relapsed and refractory multiple myeloma
Saturday, June 03, 2023The application to the European Medicines Agency is based on data from the phase III CARTITUDE study evaluating the safety profile and efficacy of ciltacel in the treatment of patients who have received up to three prior lines of therapy became
Signing of Exclusive Distributorship Agreement With EVERZOM
Saturday, June 03, 2023Summit Pharmaceuticals International Head Office Chiyodaku Tokyo Chief Executive Officer Katsuya Okuyama hereinafter SPI has signed an exclusive distributorship agreement in Japan with EVERZOM SAS hereinafter EVERZOM a Francebased company providing e...
PL BioScience and Macopharma enter into a Patent License and Assignment Agreement regarding Human Platelet Lysate (HPL) cell culture supplements.
Saturday, June 03, 2023PL BioScience GmbH a German life science company specializing in the production and development of Human Platelet Lysate HPL for cell expansion today announced a Patent License and Assignment Agreement with the French company Macopharma SAS As a resu...
Philogen Announces Clinical Trial Collaboration with MSD
Friday, June 02, 2023Philogen SpA a clinicalstage biotechnology company focused on the development of innovative medicines based on tumortargeting antibodies and small molecule ligands announces that it has entered into a Clinical Trial Collaboration and Supply Agreement...
Eikon Therapeutics Acquires Global Rights to Clinical-Stage Assets and Announces Emerging Drug Development Pipeline
Friday, June 02, 2023Eikon Therapeutics Inc a biotechnology company that is advancing breakthrough therapeutics through the purposeful integration of engineering and science today announced it has acquired exclusive rights to multiple early to midstage assets leveraging...
ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement
Friday, June 02, 2023ERS Genomics Limited ERS is pleased to announce a new license agreement with Applied Biological Materials Inc abm This is a nonexclusive licensing agreement granting abm access to the ERS CRISPRCas patent portfolio
Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd
Friday, June 02, 2023Ariceum Therapeutics Ariceum a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hardtotreat cancers is pleased to announce the acquisition of Theragnostics Ltd a UKbased private biopharmaceuti...
